Two companies aiming to create an artificial “embryo” by merging the nucleus
of a human cell with a pig egg have abandoned their attempt to patent the
process after a Greenpeace exposé. “It was never our intention to claim
patents that would cover human embryos or human reproductive cloning,” says
Julia Greenstein of BioTransplant in Charlestown, Massachusetts. Both companies
deny the decision was in response to the Greenpeace campaign, but the pressure
group is claiming victory. “These are the first biotech companies to admit
having gone too far in claiming patents on human embryos,” it says in a press
release.
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Mind
THC in cannabis may reduce nightmares in people with PTSD
News
Environment
Fishers detonate a bomb every hour on one Indonesian coral reef
News
Environment
How bad is the UK drought and how long will it continue?
News
Popular articles
Trending New Scientist articles